Global Hyaluronic Acid Market Size, Share, Growth, Strategies, and Forecast to 2025.

1. GLOBAL MARKET ESTIMATES RESEARCH &CONSULTANTS Ankita Roy, Treesha Banerjee and Liza D’souza from Global Market Estimates throw the spotlight on the growing Hyaluronic AcidMarket. Hyaluronic Acid MarketInsights The Hyaluronic Acid market is projected to grow at a significant CAGR during the forecast period. Extensive use of hyaluronic acid in dermatology is expected to have a positive impact on the market. This growth can be attributed to the growing number of people opting for aesthetic non-surgical procedures and growing geriatricpopulation. Rising disposable income of individuals has led to consumers spending more on aesthetic non- surgical procedures such as hyaluronic acid injections. Factors such as the high cost of the procedure and side-effects associated with hyaluronic acid are some factors expected to hinder the market up to a certainextent. Hyaluronic Acid Market: ByApplication The Hyaluronic Acid market can be segmented based on basis of application into dermal fillers, osteoarthritis, ophthalmic and vesicoureteral reflux among others. The osteoarthritis segment can be segmented further into a single injection, three injections, and five injections among others. The dermal fillers segment is expected to hold the largest market share in terms of revenue during the forecast period. The desire to look healthy and young and high effectiveness of dermal fillers is incliningmenandwomentooptforthisprocedure. ©COPYRIGHT 2017 GLOBAL MARKET ESTIMATES RESEARCH &CONSULTANTS

2. GLOBAL MARKET ESTIMATES RESEARCH &CONSULTANTS The osteoarthritis segment is also expected to grow at a substantial CAGR. Within the segment, three injection segment is projected to hold the largest market share in terms of revenue, while the single injection segment is expected to grow at the highest CAGR. The ophthalmic applications segment is expected to grow at the fastest rate owing to the growing incidence of cataract, glaucoma, dry eyes and age-related maculardegeneration. Hyaluronic Acid Market: RegionalInsights North America is expected to dominate the hyaluronic acid market, with the U.S. being the major contributor. High disposable income of the population and their awareness about aging is expected to drive the market in the region. The Asia Pacific region is projected to register high growth rate in the coming years. Japan is expected to contribute a major share to the growth in Asia Pacific region due to its high geriatricpopulation. Hyaluronic Acid Market: End-UseLandscape The end-use landscape entails a list of current and prospective consumers prevailing across the regions. This section provides company addresses, contact details, products, and regional presence of companies who are purchasing or are likely to purchase electrochromic material over the coming years. Some companies which are currently using hyaluronic acid and are likely to purchase it in future such as Shiseido, Proctor & Gamble Co and Unilever amongothers. ©COPYRIGHT 2017 GLOBAL MARKET ESTIMATES RESEARCH &CONSULTANTS

3. GLOBAL MARKET ESTIMATES RESEARCH &CONSULTANTS • Hyaluronic Acid Market: VendorLandscape • The report contains a chapter dedicated to vendors operating in the market, covering raw material manufactures, equipment developers, manufacturers, and distributors. The report provides these insights on a regional level. This section of the report entails contact details, experience, products manufactured/supplied, and geographical presence ofcompanies. • Hyaluronic Acid Market: Share &Competitor Analysis • Some of the key players operating in the Hyaluronic Acid markets are Allergan, Inc.; Sanofi (Genzyme); Salix Pharmaceuticals; Seikagaku Corporation; Galderma S.A., Zimmer Holdings, Inc.; Smith & Nephew Plc; Ferring Pharmaceuticals, Inc.; Anika Therapeutics, Inc.; and F. Hoffmann-La RocheLtd. • In 2016, Genzyme Corporation received FDA approval for its single injection treatment. Presence of high-molecular-weight polymers of hyaluronic acid in the product is used as a lubricant to reducethe pain caused byosteoarthritis. • In March 2016, Anika Therapeutics launched its viscosupplement Cignal which is a combination of viscosupplement and steroids that help alleviateknee pain • In 2015, Actavis acquired Allegran, which a manufacturer of hyaluronic acid based ophthalmic dermatologic and aestheticproducts. • The reportsegmentstheHyaluronicAcidMarketonthebasisof: ByApplication • DermalFillers • Osteoarthritis • Ophthalmic • VesicoureteralReflux ©COPYRIGHT 2017 GLOBAL MARKET ESTIMATES RESEARCH &CONSULTANTS

4. GLOBAL MARKET ESTIMATES RESEARCH &CONSULTANTS • ByRegion: • NorthAmerica • Europe • AsiaPacific • Central & SouthAmerica • Middle East &Africa * This article contains text from the ‘Global Hyaluronic Acid Market– Forecast to 2025’ report For moreinformationortobuythereport,please visit:https://www.globalmarketestimates.com/hyaluronic-acid-market/ *Check our annual research partnership service at: https://www.globalmarketestimates.com/annual-research-partnership-services/ ©COPYRIGHT 2017 GLOBAL MARKET ESTIMATES RESEARCH &CONSULTANTS